2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries
| BMYMP Stock | USD 1,006 15.55 1.57% |
Slightly above 55% of Bristol-Myers Squibb's retail investors are presently thinking to get in. The analysis of overall sentiment of trading Bristol Myers Squibb pink sheet suggests that some investors are interested at this time. Bristol-Myers Squibb's investing sentiment overview a quick insight into current market opportunities from investing in Bristol Myers Squibb. Many technical investors use Bristol Myers Squibb stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Bristol-Myers |
2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries
Read at kalkinemedia.com
 |
Bristol-Myers Squibb Fundamental Analysis
We analyze Bristol-Myers Squibb's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bristol-Myers Squibb using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bristol-Myers Squibb based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Annual Yield
Annual Yield Comparative Analysis
Bristol Myers is currently under evaluation in annual yield category among its peers. Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Bristol Myers Squibb Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bristol-Myers Squibb pink sheet to make a market-neutral strategy. Peer analysis of Bristol-Myers Squibb could also be used in its relative valuation, which is a method of valuing Bristol-Myers Squibb by comparing valuation metrics with similar companies.
Peers
Bristol-Myers Squibb Related Equities
| DSKYF | Daiichi Sankyo | 8.25 | ||||
| AZN | AstraZeneca PLC | 1.68 | ||||
| GSK | GlaxoSmithKline PLC | 1.05 | ||||
| CHGCY | Chugai Pharmaceutical | 0.83 | ||||
| NVS | Novartis | 0.74 | ||||
| AZNCF | AstraZeneca PLC | 0.64 | ||||
| SNY | Sanofi ADR | 0.42 | ||||
| ALPMF | Astellas Pharma | 0.72 | ||||
| RHHBY | Roche Holding | 0.79 | ||||
| RHHVF | Roche Holding | 1.09 | ||||
| BAYZF | Bayer AG | 3.14 | ||||
| ALPMY | Astellas Pharma | 3.45 | ||||
| NVSEF | Novartis | 6.43 |
Additional Tools for Bristol-Myers Pink Sheet Analysis
When running Bristol-Myers Squibb's price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.